Hancock Whitney’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-47,402
Closed -$459K 799
2025
Q2
$459K Buy
47,402
+5,939
+14% +$61.3K 0.01% 577
2025
Q1
$617K Buy
41,463
+12,462
+43% +$192K 0.02% 403
2024
Q4
$433K Sell
29,001
-18,181
-39% -$296K 0.01% 459
2024
Q3
$903K Buy
47,182
+4,637
+11% +$96.1K 0.03% 331
2024
Q2
$881K Buy
+42,545
New +$845K 0.03% 325

Other funds holding OGN

Hancock Whitney's OGN Position: Q3 2025 in Review

Hancock Whitney sold out of Organon & Co (OGN) in Q3 2025, closing a stake of 47,402 shares — an estimated $459K sold.

Hancock Whitney first reported a position in OGN in Q2 2024 and held it in 5 quarters. The position peaked at $903K in Q3 2024. 670 funds tracked by Wall St. Rank hold OGN as of Q3 2025.

  • Hancock Whitney reported no remaining Organon & Co position as of Q3 2025 after selling out during the quarter.
  • Hancock Whitney sold 47,402 Organon & Co shares in Q3 2025, an estimated $459K.
  • Hancock Whitney first reported a position in Organon & Co in Q2 2024 and held it in 5 quarters.
  • Hancock Whitney's Organon & Co position peaked at $903K in Q3 2024.
  • 670 funds tracked by Wall St. Rank held Organon & Co as of Q3 2025.

Based on Hancock Whitney's 13F filing for Q3 2025, filed 17 Nov 2025.